Does Mono eCTD Office support FDA and EMA v4.0 publishing?

Its current product page explicitly says so. Obtain the supported release, regional implementation and lifecycle operations, then test your required package; the general statement is not proof of every procedure.

Does a free Mono Viewer include Office publishing?

No. Mono identifies a separate Viewer with edition-specific viewing features. Evaluate the full Office suite and its quoted scope when publishing is required.

Can Assyro replace NeeS or VNeeS publishing?

Those formats are outside the approved Assyro eCTD scope. Retain a capable workflow for them and evaluate Assyro only against an in-scope requirement.

Does a validator guarantee authority acceptance?

No. Technical checks support a release decision; they do not establish scientific adequacy, the correct approved content or acceptance by the receiving authority.

Comparison/Updated October 2026

Assyro eCTD vs Mono eCTD Office

Compare the complete publishing suite, the required regional output and the work that happens before a document becomes a submission leaf.

Assyro eCTD

by Assyro AI

A cloud drafting, checking and eCTD production workflow with related DMS.

Cited draftingCloud workspaceConnected DMSUnlimited users

Mono eCTD Office

eCTD, NeeS and VNeeS publishing suite

A submission compilation and lifecycle suite with document preparation, validation and review utilities.

eCTD / NeeS / VNeeSPDF utilitiesLifecycle toolsFDA/EMA v4.0 listed

The verdict

Evaluate Assyro eCTD when drafting with source grounding is part of the problem and your required package fits its approved scope. Evaluate Mono eCTD Office when its verified eCTD, NeeS or veterinary NeeS workflow and document utilities match the project. Mono's current suite page explicitly describes FDA and EMA v4.0 publishing. A free or paid Mono Viewer licence is a different purchase from the full Office publishing suite.

Written individually by Assyro AI, a compared vendor. Current Mono Office and Viewer primary pages checked October 13, 2026. No independent benchmark, matched pricing quote or authority endorsement is claimed.

Start with the required format

A wider format list is valuable only when those outputs are part of your actual filing plan.

Initial scope decisions
Job	Assyro	Mono
Source-grounded writing	Evaluate eCTD drafting	Confirm current content-authoring scope
NeeS/VNeeS	Outside approved scope	Office suite lists these formats
v4.0 publishing	FDA; EMA initial MAA	FDA/EMA stated; verify exact profile
Read a partner dossier	Define required review workflow	Evaluate Viewer separately from Office

Source-grounded writing
Assyro
Evaluate eCTD drafting
Mono
Confirm current content-authoring scope
NeeS/VNeeS
Assyro
Outside approved scope
Mono
Office suite lists these formats
v4.0 publishing
Assyro
FDA; EMA initial MAA
Mono
FDA/EMA stated; verify exact profile
Read a partner dossier
Assyro
Define required review workflow
Mono
Evaluate Viewer separately from Office

[1][2][3]

The output profile and source record both need acceptance

Assyro's approved v3.2.2 scope covers FDA, Health Canada and EMA centralised. Do not broaden that boundary from a generic regional name. For either vendor, request the actual release, regional technical profile and supported operation.

Keep the source-to-output relationship visible. A PDF utility solves document preparation; it does not by itself establish that the right approved source was used. Require the source manifest and retained earlier output.

[3]

Feature by feature

Published capabilities, related applications and evidence still to request.

Draft submission sections
Assyro eCTD
Source-grounded drafting[3]
eCTD Office
Demonstrate any required drafting/AI functionality[1]
Compile, validate and publish
Assyro eCTD
Approved eCTD profiles[3]
eCTD Office
Publishing suite; confirm regional implementation[1]
NeeS and VNeeS
Assyro eCTD
Outside approved eCTD scope[3]
eCTD Office
Listed suite formats[1]
eCTD v4.0
Assyro eCTD
FDA and EMA initial MAA scope[3]
eCTD Office
FDA and EMA publishing stated; verify release and operation[1]
Controlled source documents
Assyro eCTD
Related Assyro DMS[4]
eCTD Office
Confirm controlled-record and approval requirements[1]
Price scope
Assyro eCTD
Custom, unlimited users[5]
eCTD Office
Request Office suite terms; Viewer editions are separate[1][2]

Assyro eCTD and Mono eCTD Office: feature comparison
Capability	Assyro eCTD	eCTD Office
Draft submission sections	Source-grounded drafting[3]	Demonstrate any required drafting/AI functionality[1]
Compile, validate and publish	Approved eCTD profiles[3]	Publishing suite; confirm regional implementation[1]
NeeS and VNeeS	Outside approved eCTD scope[3]	Listed suite formats[1]
eCTD v4.0	FDA and EMA initial MAA scope[3]	FDA and EMA publishing stated; verify release and operation[1]
Controlled source documents	Related Assyro DMS[4]	Confirm controlled-record and approval requirements[1]
Price scope	Custom, unlimited users[5]	Request Office suite terms; Viewer editions are separate[1][2]

Product details and recommendations reflect publicly available information and our own assessment as of October 2026, provided for comparison. Mono eCTD Office is a product of Mono; trademarks belong to their respective owners.

Which one should you choose?

Choose Assyro eCTD if

Writers need source traceability before package assembly.
Your required authority/version/operation fits the approved Assyro workflow.
The team wants to pilot drafting and controlled-source handoffs together.

Choose eCTD Office if

NeeS or veterinary NeeS is a required output.
Your publishing plan includes regional profiles beyond approved Assyro scope.
The included PDF, hyperlink and comparison utilities pass your actual document tasks.

The detailed comparison

Are you buying a viewer or a publishing workflow?

Assyro eCTD

Define whether the job ends at reading an existing sequence or producing a new one. Include source approval and package release when evaluating publishing.

eCTD Office

Mono names Office, Viewer and Validator separately. A Viewer trial or price cannot establish the Office suite's authoring, publishing, access or deployment terms.

[1][2][3]

Which document-preparation tasks should decide the pilot?

Assyro eCTD

Use a source section requiring review and correction. Inspect citation correctness, the approved revision and the final exported file rather than treating fluent output as evidence.

eCTD Office

Use a difficult PDF with cross-document links, a changed file and a historical lifecycle target. Have the intended operator locate and correct problems, then retrieve the prior accepted output.

[1][3]

Request suite terms rather than substituting Viewer prices

Obtain the Office licence, user/device restrictions, environments, support, update and required-region terms. Mono states support and updates are included on the suite page; confirm the contract, release notice and escalation process. Public Viewer pricing is not an Office quote.

Compare the Assyro proposal for the same accepted workflow, including related DMS if needed. Add document preparation, import reconciliation, training, release assessment, retained format-specific tools and exit work. No lower-cost conclusion is supported without matched proposals.

[1][2][5]

Use a troublesome document and a changed sequence

Have the intended operator complete the tasks; record help required and unresolved errors.

Source fidelity

Correct a drafted or prepared section and prove the accepted file matches the approved revision.

Link integrity

Find an intentionally broken cross-document reference, fix it and inspect the export in a separate viewer.

Lifecycle continuity

Import previous sequences, target a historical item and verify current and earlier views.

Operations

Apply a required profile update, retrieve release evidence and export a reviewable record set for exit.

Where eCTD Office is stronger

No tool wins on everything. Here is where eCTD Office is the better choice today.

The suite explicitly spans eCTD, NeeS and VNeeS workflows.
Its published utilities include PDF preparation, hyperlink auditing and submission comparison.
Current FDA/EMA v4.0 publishing scope merits an actual output pilot rather than an outdated omission claim.

Adopting Assyro eCTD

Retain Mono for required formats that Assyro does not offer. For an in-scope application, test a complete history and next sequence before changing the authoritative publisher. No automatic synchronization or preservation of native legacy evidence is established here.

1Separate programs by required authority, format and version.
2Retain original sequences and accepted source records.
3Map and import a representative in-scope history.
4Reconcile references and produce the required next operation.
5Approve exceptions, authoritative record ownership and rollback.

Sources and evidence

Product documents establish published scope. Evaluation scenarios and recommendations are Assyro's analysis. Confirm availability, configuration and contract scope with each vendor.

Mono eCTD Office
Formats, productivity utilities and current FDA/EMA v4.0 publishing statement; checked October 13, 2026; no release revision displayed
Mono eCTD Viewer editions
Separate Viewer editions, restrictions and annual/computer pricing; checked October 13, 2026; not Office publishing-suite pricing
Assyro eCTD product scope
Published product definition and capability scope; checked October 13, 2026; related applications require their own quoted scope
Assyro DMS product scope
Published product definition and capability scope; checked October 13, 2026; related applications require their own quoted scope
Assyro pricing
Published custom pricing and unlimited users on every plan; checked October 13, 2026; no competitor price advantage inferred